Skip to main content

Not Found
Product Type
On Demand

Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
   0
Faculty:
Joseph Johnson, DO
Price:
$40.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
   0
Faculty:
Eric Stanley, DO
Price:
$40.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: 1 including 1 AOA Category 2-A Credit

Average Rating:
   0
Faculty:
Jessica Ailani, MD
Price:
$40.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
   0
Faculty:
Corey Cavanaugh, DO
Price:
$40.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: .5 including .5 AOA Category 1-A Credit(s)

Average Rating:
   0
Faculty:
Corey Cavanaugh, DO
Short Description:
Chronic kidney disease (CKD) is a common, yet under recognized problem in America. In the last 5 years, a number of studies have been published describing new therapies to combat CKD and lower the rate of end stage kidney disease. This presentation will cover these studies regarding SGLT2 inhibitors, mineralocorticoid receptor antagonists, and GLP-1 agonists to name a few. The goal is to provide practical and concise information, such that physician inertia in prescribing these therapies can be overcome.
Price:
$35.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: 1.5 including 1.5 AOA Category 1-A Credit(s)

Average Rating:
   0
Faculty:
Jeffrey Groesbeck, DO
Price:
$40.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: .75 including .75 AOA Category 1-A Credit(s)

Average Rating:
   0
Faculty:
David Killeen, DO
Price:
$35.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: 2 including 2 AOA Category 1-A Credit(s)

Average Rating:
   0
Faculty:
Saunora Prom, DO |  Jason McHugh, DO
Price:
$40.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
   0
Faculty:
Joseph Secor-Taddia, DO
Short Description:
Musculoskeletal complaints are present in 48% of the population and are the second-most reported reason patients PCPs. OMT has been shown to effectively treat many conditions such as low back pain with a reduced cost and need for concomitant medication use or medical intervention. OMT use among osteopathic physicians in the US continues to decline. Statistically significant barriers include lack of reimbursement, lack of time, lack of institutional practice/support, and lack of confidence/proficiency. The goal of this presentation is to provide insight for DOs to overcome these barriers to incorporating OMT into their practice.
Price:
$40.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: 2 including 2 AOA Category 1-A Credit(s)

Average Rating:
   0
Faculty:
David Harden, DO
Price:
$80.00 - Base Price

Please wait ...

Back to Top